We are a team of scientists, engineers, and MDs.

Karl Trygve Kalleberg

Karl Trygve is a Medical Doctor with experience within the field of Internal Medicine and Nephrology. He has extensive experience in Predictive Analysis and holds a PhD in Computer Science. He is a cofounder of Age Labs and has extensive experience in business development, as co-founder of KolibriFX, Sensonomic and Quantility

Arne Søraas

Arne is a Medical Doctor with a specialist degree in both Internal Medicine and Infectious Diseases, and holds a PhD in microbiology. He is a cofounder of Age Labs and has previous experience in business development as founder and CEO of Boklisten

Espen Riskedal

Espen holds a Masters Degree in Computer Science and has experience in the field of Bioinformatics. He is a cofounder of Age Labs and has previous experience from business development as founder and CEO of Cutehacks

Cathrine Hadley

Cathrine is a Medical Doctor with clinical experience within the fields Internal Medicine and Cardiology, She has experience in running large clincial multicenter trials and holds a PhD in Acute Medicine. She has studied Business, Administration and Marketing at Oslo Business School

Jan Fikkan

Jan is the CEO of Fikkan Pharma, and an expert in business and negotiation outcome modeling. He is the former general manager GE Healthcare Japan. Jan has 20+ years of international leadership experience at a senior/executive level from the Pharmaceutical industry.

Espen Riskedal

Espen holds a Masters Degree in Computer Science and has experience in the field of Bioinformatics. He is a cofounder of Age Labs and has previous experience from business development as founder and CEO of Cutehacks

Arne Søraas

Arne is a Medical Doctor with a specialist degree in both Internal Medicine and Infectious Diseases, and holds a PhD in microbiology. He is a cofounder of Age Labs and has previous experience in business development as founder and CEO of Boklisten

Einar Brummenæs

Einar is the CEO at Monolit, a data science company focusing on global financial markets. He is an expert in software and algorithm development with extensive experience from the financial industry, including 4 years at JP Morgan. Einar has a BSc in Investments and Financial Risk Management from Cass Business School.

John Arne Dahl

John Arne is a research group Leader at the Clinic for Laboratory Medicine at Oslo University Hospital. His group works on genome and epigenome regulation in embryo development, aging and disease (Dahl et al., Nature 2016; Søraas et al., Aging Cell 2019). Aging related projects focus on stem cell aging, rejuvenation after hematopoietic stem cell transplantation in healthy humans, and cancer. He holds a PhD in molecular biology from the University of Oslo.

Espen A. Haavardsholm

Espen A. Haavardsholm is the center director of REMEDY (Center for treatment of Rheumatic and Musculoskeletal Diseases), Professor in Rheumatology, UiO and Head of Research and Innovation at Diakonhjemmet Hospital (EULAR Center of Excellence). In 2008 he received the the King’s Gold Medal for his Ph.D., as well as a EULAR Young Investigator Award in 2009. Since then Espen has focused on treatment of rheumatic diseases, and initiated several large multicenter studies investigating novel treatment strategies.

Siri Lillegraven

​Siri is the deputy director of REMEDY (Center for treatment of Rheumatic and Musculoskeletal Diseases), a senior researcher and Unitlead for Clinical Research at Diakonhjemmet Hospital (EULAR Center of Excellence). Siri is a Medical Doctor with a PhD focusing on joint damage in rheumatoid arthritis. Siri has studied at Harvard School of Public Health. In 2022 the Norwegian Medical Association (NMA) awarded Siri for her work as first on the ARCTIC REWIND study published in JAMA.

Silje Watterdal Syversen

Silje is the Head of the Norwegian society for rheumatology, and works as a senior rheumatologist and postdoctoral researcher at REMEDY (Center for treatment of Rheumatic and Musculoskeletal Diseases) and Diakonhjemmet Hospital (EULAR Center of Excellence). Silje´s PhD focused on how RA biomarkers can predict joint destruction. Her current fields of interest are therapeutic drug monitoring, biomarkers, autoantibodies, clinical treatment studies, epidemiology.

Guro Løvik Goll

Guro is a senior rheumatologist and postdoctoral researcher at REMEDY (Center for treatment of Rheumatic and Musculoskeletal Diseases) and Diakonhjemmet Hospital (EULAR Center of Excellence). Guro spends her time equally between the clinic and doing research. Guro´s fields of interest​ are advanced drug treatment of inflammatory rheumatic disease, biomarkers, drug monitoring, biosimilar medicines, synovial biopsies and autoimmunity.

Siri Strand

Siri holds a PhD in molecular medicine. She has more than 12 years’ experience in translational cancer research, having used molecular techniques and computational models to address clinically relevant questions, specifically within biomarker research, working at institutions such as Aarhus University, Aarhus University Hospital and Stanford University School of Medicine.

Timo Braun

Timo holds an MSc in physics and is currently finishing his PhD in statistics. He has experience with developing novel machine learning methods, with particular focus on gaussian processes for online learning regression.

Mette Stausland Istre

Mette holds a Masters Degree in Biotechnology with a primary interest in the field of Molecular Biology. She has previous experience with data collection for clinical trials, in addition to various DNA extraction methods from human samples and their analysis

Gudmund Hermansen

Gudmund’s field of research is in theoretical statistics. He is associate professor II in statistics at the University of Oslo. He also previously worked as head of data science and statistics at Abelee and at Norsk Regnesentral (The Norwegian Computing Center) as a senior researcher. Gudmund brings valuable experience, competence and capacity to Age Labs.

Nils Reinton

Nils works as the R&D lab manager at Fürst Medical laboratories and acts as liaison on our common R&D projects. Nils holds a master’s degree in genetic counseling, and a PhD in molecular biology. Nils founded the molecular biology department at Fürst and has since been responsible for both daily management and business development, for the molecular biology activities in Fürst. He publishes scientific articles regularly in laboratory fields such as clinical chemistry, microbiology and genetics

Håkon Bøås

Håkon is employed at the Norwegian Institute of Public Health (NIPH) and works 60% on our common R&D projects. Håkon holds a master’s degree in cellular and molecular biology, and a PhD in molecular epidemiology. He has worked on several national and international research projects, focusing on infectious respiratory diseases, and on development of autoimmune diseases like type 1 diabetes

Jennifer Ruth Harris

Jennifer is the Director of Research in the Division of Health Data and Digitilsation at the Norwegian Institute of Public Health (NIPH) where she is also a researcher in the Centre for Fertility and Health. She has interdisciplinary training in life-span development and genetics. Her research has exploited the twin design to conduct studies on a wide range of research questions including epigenetic studies, cancer, studies of social factors and health. Through a series of EU projects in genetic epidemiology she has also been active in developing initiatives for international biobank harmonization.

Astanand Jugessur

Jugessur is a senior scientist at the Norwegian Institute of Public Health (NIPH) and an adjunct associate professor at the University of Bergen. He has multidisciplinary training in genetic epidemiology and has contributed numerous insights to this field of research. His team has secured several grants, which have helped spearhead a rich portfolio of research into telomeres and epigenetic age. One of the NRC grants is with Age Labs, where the aim is to develop a measurement of biological age in humans based on DNA methylation to accelerate the development of new therapies for age-related disease.